Milestone Scientific Inc. (MLSS)
MLSSAMEXIndustrial Specialties
$0.3020
+0.0120 (+4.14%) today
At the close, Nov 9, 4:00 PM ET. Pre-market $0.2901 -3.94%
- Market cap
- $27.17m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- $0.2900 to $0.3200
- 52-week range
- $0.2181 to $0.5796
- Average volume
- 464.8k
- Previous close
- $0.2900
Analysts
1 coveringBuy1 buy, 0 hold, 0 sell
Targets a year out average $1.50, +396.7% from here
Earnings
Next report Nov 12, 2026
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | $2.36m | $2.06m | $2.16m | $2.84m |
| Gross profit | $1.64m | $1.50m | $1.56m | $1.91m |
| Operating income | -$1.13m | -$1.08m | -$828.0k | -$1.06m |
| Net income | -$1.15m | -$1.09m | -$840.0k | -$1.06m |
Last four quarters: revenue $9.42m, margin -44.0%, free cash flow -$657.0k
News
8 latest- Weekly Buzz: RARE, BAYRY Win Approvals; SION Cuts Jobs, GSK Deals; AZN, RHHBY Lead RTTNews · Sep 18, 2026
- Milestone Scientific Partners With Pain And Spine Specialists On CompuFlo Development; Stock Up RTTNews · Sep 16, 2026
- Milestone Completes Debt-To-Equity Conversion With Board Members At $0.50 Per Share RTTNews · Aug 26, 2026
- Milestone Scientific Q4 Net Loss Narrows; Expects Approx. 9% To 14% Revenue Growth In FY26;Stock Up RTTNews · Apr 1, 2026
- Milestone Scientific (MLSS) Price Target Decreased by 50.00% to 1.02Fintel · Dec 5, 2025
- Benchmark Maintains Milestone Scientific (MLSS) Speculative Buy RecommendationFintel · Nov 20, 2025
- Applied Therapeutics, Omeros, And Others Post Sharp Moves After Market Close RTTNews · Nov 13, 2025
- Milestone Scientific (MLSS) Price Target Increased by 23.08% to 2.04Fintel · Oct 29, 2025
The company
Milestone Scientific Inc. is a technology-focused medical research and development company that patents, designs, and develops innovative injection technologies and instruments for medical and dental applications. Milestone Scientific's computer-controlled systems are designed to make injections precise, efficient and increase the overall patient comfort and safety. Their proprietary DPS Dynamic Pressure Sensing Technology instruments is the platform to advance the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions of subcutaneous drug delivery, including local anesthetic. To learn more, view the MLSS brand video or visit milestonescientific.com.
- Sector
- Health Care
- Industry
- Industrial Specialties
- Exchange
- AMEX
- Region
- North America
- Website
- milestonescientific.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.